Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal



Similar documents
Withdrawal Symptoms: How Long Do They Last?

COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE

KAP Keys. For Physicians. Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment. of Opioid Addiction

Benzodiazepines: A Model for Central Nervous System (CNS) Depressants

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT

Information for Pharmacists

Guidance for Disease Management in Correctional Settings OPIOID DETOXIFICATION

How To Know If You Should Be Treated

CONTROLLED SUBSTANCE CONTRACT

Opioids Research to Practice

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

Opioids Research to Practice

Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal

Opioid Agreement for Center for Pain Management S.C.

Alcohol and nicotine are widely abused substances and are often used together One study showed that 15% of patients visiting a primary care practice

The CCB Science 2 Service Distance Learning Program

Use of Buprenorphine in the Treatment of Opioid Addiction

Alcohol Withdrawal Recognition and Treatment

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

Benzodiazepine Detoxification and Reduction of Long term Use

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Update on Buprenorphine: Induction and Ongoing Care


Hulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013

Downers/Depressants (pages 40-50)

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

Prescription Drug Addiction

Comprehensive Behavioral Care, Inc. Level of Care Guidelines Substance Abuse Children/Adolescents

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13

Residential Sub-Acute Detoxification Guidelines

What Is a Withdrawal Syndrome?

Program Assistance Letter

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Ohio Legislative Service Commission

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Using Buprenorphine to Treat Acute Opioid Withdrawal in the ED

EPIDEMIOLOGY OF OPIATE USE

OTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?

Benzodiazepines. And Sleeping Pills. Psychological Medicine

Treatment of opioid use disorders

Update and Review of Medication Assisted Treatments

Buprenorphine: what is it & why use it?

Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings

Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction

Pain Medication Taper Regimen Time frame to taper off days

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Naltrexone and Alcoholism Treatment Test

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Methadone treatment Information for service users Page

CONTROLLED SUBSTANCE (NARCOTIC) AGREEMENT

UNIT VIII NARCOTIC ANALGESIA

Detox Day. RCGP June 13 th Daphne Rumball Addictions Psychiatrist. Norfolk. Daphne Rumball RCGP Detox Day June

Care Management Council submission date: August Contact Information

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Prescription Drug Abuse

Management of Opiate Dependence in the Outpatient Setting

10/28/2014. Collecting the Raw Opium

Joanna L. Starrels. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VIII, A. Study Purpose and Rationale

How to Manage Adjustment of Psychiatric Drugs. Choosing an Agent. Psychotropic Agents

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

Non medical use of prescription medicines existing WHO advice

M a n a g i n g t h e P a i n Commonly used terms Ask the right questions LPN2009

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

Financial Disclosures

One example: Chapman and Huygens, 1988, British Journal of Addiction

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

Prescription Drugs: Abuse and Addiction

DrugFacts: Treatment Approaches for Drug Addiction

MEDICATION ABUSE IN OLDER ADULTS

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Prescribing and Tapering Benzodiazepines

ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting

Oxford Health NHS Foundation Trust. A guide to Opioid Detoxification

Benzodiazepines. Understanding psychiatric medications. Information for consumers, families and friends. Titles in the

Ambulatory Intoxication and Withdrawal Management: A Clinical Monograph

How To Treat Anorexic Addiction With Medication Assisted Treatment

What is Methadone? Opioid Treatment Programs Today. Is Methadone Safe? Pain Clinics. Wisconsin OTPs. Methadone Maintenance Treatment 5/6/2013

Substance Abuse Protracted Withdrawal. Kate Speck, PhD, MAC, LADC

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

It is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.

Opioid Treatment Services, Office-Based Opioid Treatment

Co-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Opioid overdose can occur when a patient misunderstands the directions

STATISTICS. Opiate Substitution Therapy for Opiate Dependence. Alan Shein, M.D.

Substance Use Disorder Overview. Presented By Ecole J. Barrow-Brooks M.Ed & Darlene D. Owens MBA, LBSW, CADC, ADS

Science and Treatment Prescription Drug Addiction Treatment. Karen Miotto, M.D. David Geffen School of Medicine

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Alcohol Withdrawal Syndrome & CIWA Assessment

Withdrawal symptoms in long term sedation exposure of pediatric intensive care patients

Office-based Opioid Dependence Treatment with Buprenorphine

Opioids, Benzos, and Tapering, Oh My! Disclosures

Transcription:

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1

It is legal in every state to taper a pain patient s medication slowly to avoid withdrawal symptoms. Unless you have special certification, in most states it is NOT legal to detoxify a substance abuser. There are gray areas and certain circumstances where a pain doctor will need to handle withdrawal including hospitalized patients, non abusing patients with physical dependence, patient requests, etc. Tapering versus Detoxification To use schedule II opiates for detoxification from opiate addiction, a special registration is required: (21 Code of Federal Regulation 1306.07(a)). Drug Abuse Treatment Act of 2000 allows physicians to use schedule III agents to detoxify chemical dependent patients in an office setting, provided the physician qualifies for and obtains a waiver issued through the Substance Abuse and Mental Health Services (SAMHSA) and the DEA. ** ** State regulations may require further registration 2

Tapering when it is necessary to discontinue a pain patient's opioid therapy by tapering or weaning doses, there are no restrictions with respect to the drugs that may be used. This is not considered "detoxification" as it is applied to addiction treatment. Patricia Good, Chief of Policy Section, Office of Diversion and Control Opioid Withdrawal Symptoms Opiate craving Sweating Restlessness Nervousness Fatigue Rhinorrhea Dilated pupils Yawning Increased respiration Irritability Anxiety Dysphoria Piloerection Muscle twitching Headache Anorexia 3

Severe Opioid Withdrawal Symptoms Fever Tachycardia Cutaneous Hypersensitivity Hypertension Isomnia Hot/cold flashes Nausea Vomiting Bone pain Muscle Aches/spasms Abdominal Cramps Diarrhea Benzodiazepine / Sedative Withdrawal Symptoms Anxiety / Agitation Hypertension / Tachycardia Sensory Hypersensitivity Insomnia Confusion / Delerium Cramps / Hyperreflexia Seizures Nightmares Mania Tremor / Fasciculations Tinnitus / Dizziness Lethargy 4

Time Course of Withdrawal Onset proportional to T1/2 of agent, daily amount. Duration somewhat proportional to rate of receptor turnover. Duration somewhat proportional to T 1/2 of agent. Severity somewhat proportional to daily dose. Severity less proportional to duration of use. Sedative Hypnotic and Benzodiazepine Tapering 5

Sedative / Benzo Withdrawal Peak symptoms not for 3-6 days Duration of withdrawal 3-6 weeks Mentation may improve for more than 6 months. Secondary symptoms (insomnia, anxiety, etc.) may not normalize for a year. Symptom rebound occurs - it is not withdrawal. INSOMNIA - 1 year plan. Sedative / Benzo Withdrawal CAN BE FATAL!! Concurrent alcohol use / abuse in 1/3 of benzodiazepine dependent patients. Severity of withdrawal seems worse in females. Patients with abuse history, strong family history of abuse, concurrent daily alcohol, significant psychiatric issues are not candidates for tapering. 6

Benzodiazepine Tapering Dose reduced 10% to 20% every 2 weeks. If withdrawal Sxs occur hold at that level for 1 month. The final 20% should be tapered over a month. Benzodiazepine Cross Tapering Chlordiazepoxide, Clonazepan, Phenobarbital are most commonly used. Patient started on equivalent dose, may need to be increased until stable. Stable dose continued 1 week, then reduced 20% every 3 days. The last 25% of dose is removed over 2 weeks. Cross tapering is recommended for Alprazolam and Soma tapering - but rate of tapering may need to be slower. 7

Opioid Tapering Opioid Withdrawal Onset 6 hours (short acting) to 36 hours (methadone). Peak Sxs 12 hours (short) to 72 hours (long acting). Duration 5 to 14 days. Secondary withdrawal - episode of withdrawal symptoms lasting hours to a couple of days - may occur for 6 months. 8

Standard Opioid Tapering Minor withdrawal symptoms occur 10% dose reductions per day or 25% every 3 days usually tolerated well. Clonidine 0.2 mg q 4-6 hours markedly reduces withdrawal severity. Usually tapered over 10 to 14 days. Low dose benzodiazepines or TCAs may also be useful. Rapid Detoxification Naltrexone or Buprenorphine, with or without clonidine and benzodiazepine. Withdrawal symptoms are more pronounced than tapering on first day. Withdrawal process is quicker. Long acting partial agonist minimizes effect of opiate if patient cheats. 9

Buprenorphine Detoxification Not appropriate for high dose opioids: majority of patients at 60 mg Methadone per day will have withdrawal symptoms. Usually begin after 12 hours abstinence - patient in mild withdrawal. Begin with 2 mg dose SL, repeated every 2 hours to maximum 16 or even 32 mg first day.. Once stable dose is reached it is usually continued for 2 to 3 days Patient is then tapered over 2 to 3 weeks. May use adjunctive medications if needed. Buprenorphine Detoxification from Long Acting Opiates Taper to methadone 30 mg / day equivalent 24 hrs after last dose, give buprenorphine 2 mg Withdrawal symptoms present? Yes Give buprenorphine 2 mg Withdrawal symptoms continue? Yes Repeat dose up to maximum 8 mg/24 hrs No No Daily dose established Withdrawal symptoms relieved? No Manage withdrawal symptomatically Daily Yes dose established Increase to 16 mg / day on day 2 Adapted from H. Heit, M. D.; www.asam.org 10

11